We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

168 hedge funds and large institutions have $2.04B invested in Medicines Co in 2013 Q2 according to their latest regulatory filings, with 168 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $15.4M

Holders
168
Holders Change
+168
Holders Change %
–
% of All Funds
5.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
168
Increased
–
Reduced
–
Closed
–
Calls
$23.6M
Puts
$15.4M
Net Calls
+$8.18M
Net Calls Change
+$8.18M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
101
D.E. Shaw & Co
New York
$1.35M +$1.47M +43,885 New
FQ
102
First Quadrant
California
$1.23M +$1.34M +40,000 New
GF
103
Gerry Farber
New York
$1.23M +$1.34M +40,000 New
MAA
104
Managed Account Advisors
New Jersey
$1.22M +$1.33M +39,634 New
WA
105
Whitebox Advisors
Minnesota
$1.2M +$1.31M +39,036 New
Macquarie Group
106
Macquarie Group
Australia
$1.11M +$1.2M +36,010 New
OC
107
Oppenheimer & Co
New York
$1.07M +$1.17M +34,910 New
CAM
108
Capstone Asset Management
Texas
$1.05M +$1.14M +34,013 New
BJ
109
BlackRock Japan
Japan
$1M +$1.09M +32,545 New
SO
110
STRS Ohio
Ohio
$969K +$1.05M +31,492 New
NLGIA
111
Nippon Life Global Investors Americas
New York
$966K +$1.05M +31,400 New
SIM
112
Spark Investment Management
New York
$922K +$1M +30,000 New
Citigroup
113
Citigroup
New York
$894K +$973K +29,079 New
NTCOC
114
Northern Trust Company of Connecticut
Connecticut
$881K +$959K +28,650 New
Calamos Advisors
115
Calamos Advisors
Illinois
$861K +$937K +28,005 New
CBOA
116
Commonwealth Bank of Australia
Australia
$809K +$880K +26,300 New
MAM
117
Martingale Asset Management
Massachusetts
$797K +$867K +25,910 New
BHTS
118
Bar Harbor Trust Services
Maine
$789K +$858K +25,660 New
Bank of Montreal
119
Bank of Montreal
Ontario, Canada
$765K +$832K +24,874 New
First Trust Advisors
120
First Trust Advisors
Illinois
$763K +$830K +24,812 New
MOACM
121
Mutual of America Capital Management
New York
$704K +$766K +22,897 New
DCM
122
Decatur Capital Management
Georgia
$701K +$762K +22,775 New
BNP Paribas Financial Markets
123
BNP Paribas Financial Markets
France
$661K +$719K +21,498 New
NCCM
124
Nine Chapters Capital Management
New Jersey
$628K +$682K +20,400 New
UBS AM
125
UBS AM
Illinois
$575K +$626K +18,698 New
3 4
5
6 7

MDCO Hedge Fund Activity: Q2 2013 in Review

168 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q2 2013, worth a combined $2.04B.

Buyers outnumbered sellers: 168 funds opened new MDCO positions and 0 closed out — a net gain of 168 holders — while 0 added to existing stakes and 0 trimmed.

  • 168 institutional investors held Medicines Co (MDCO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.04B of Medicines Co stock for Q2 2013.
  • 168 funds opened new Medicines Co positions in Q2 2013 and 0 closed out, a net change of +168 holders.

Based on aggregated 13F filings for Q2 2013.